Niva Bupa Health Insurance Company

Niva Bupa Health Insurance Company

76.40
+2.34
(3.16%)
hide
Key Fundamentals
Add Ratio
Market Cap
14,101.20 Cr
EPS
1.22
PE Ratio
152.82
Dividend Yield
0.00 %
Industry
Insurance
52 Week High
109.34
52 Week Low
68.54
PB Ratio
3.71
Debt to Equity
0.42
Analyst Rating and Forecast
- By Refinitiv from9 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+77.78 %
+77.78 %
Hold
Hold+22.22 %
+22.22 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Niva Bupa Health Insurance Company Limited announced its Q2 FY26 performance with Profit After Tax (IFRS) more than doubling to ₹62 crore from ₹24 crore in Q2 FY25. Retail Health Gross Written Premium (GWP) grew 24.5% year-over-year. The company reported overall GWP of ₹2,108 crore on a without 1/n basis and ₹1,843 crore on a with 1/n basis for Q2 FY26. For H1 FY26, the company recorded ₹3,983 crore GWP (without 1/n) and ₹3,475 crore (with 1/n). The Combined Insurance Service Ratio (IFRS) improved to 103.1%, an improvement of 141 basis points from Q2 FY25. Claims Settlement Ratio reached 95.2% and Solvency Ratio improved to 2.85x. The company covers 23.14 million lives with a Net Promoter Score of 57. Distribution channels showed Individual Agency contributing 31%, Brokers 27%, Bancassurance 20%, Direct business 10%, and Corporate Agents 11% with the fastest year-over-year growth of 44%.
positive
Niva Bupa Health Insurance Company achieved 22.9% year-on-year growth in Gross Written Premium, reaching ₹3,983 crore (without 1/n) and ₹3,475 crore (with 1/n) for H1 FY2026. The company's IFRS Profit After Tax increased to ₹132 crore compared to ₹60 crore in H1 FY2025. Combined Insurance Service Ratio improved to 103.1% from 104.2% in the previous year. Retail Health market share stands at 9.9% for H1 FY2026. The company launched ReAssure 3.0, India's first truly unlimited health insurance plan, and reported a Weighted Episodal NPS of 57, showing a 2-point improvement over FY2025. The company operates through 209 branches with 209,699 individual agents and maintains a network of 10,507 hospitals.
neutral
Niva Bupa Health Insurance Company Limited filed a statement confirming no deviation or variation in the utilization of funds raised through its Initial Public Offering. The company raised gross proceeds of INR 800 crores through the public issue with allotment date of November 12, 2024. The funds were designated for augmentation of capital base to maintain and strengthen solvency levels. For the quarter ended September 30, 2025, the company reported nil amount utilized and confirmed no deviation from the original allocation of INR 800 crores. The statement was reviewed by the Audit Committee in its meeting held on November 3, 2025.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,040.00
#1 1,01,477.90
36.27
24,000.80
16.45
2,508
18.08
63.61
375.85
65,939.10
#1 7.72
#1 49,924.60
7.53
#1 6,974
#1 80.67
46.45
360.25
33,262.30
65.49
9,695.50
12.54
425
51.51
53.74
182.22
30,029.90
25.17
43,634.00
0.32
972
65.38
35.58
488.55
28,724.30
53.86
16,113.00
14.87
646
-50.67
56.19
76.40
#6 14,101.20
#6 152.82
#6 5,529.70
#1 27.52
#6 214
#6 -371.54
46.48
Growth Rate
Revenue Growth
27.52 %
Net Income Growth
161.00 %
Cash Flow Change
103.55 %
ROE
106.20 %
ROCE
31.84 %
EBITDA Margin (Avg.)
67.70 %

Yearly Financial Results

Annual Financials
2022
2023
2024
2025
TTM
Revenue
2,159
3,223
4,336
5,530
5,886
Expenses
2,329
3,179
4,225
5,292
5,793
EBITDA
-170
45
111
238
93
Operating Profit %
-10 %
-1 %
-1 %
1 %
-10 %
Depreciation
27
32
29
25
0
Interest
0
0
0
0
0
Profit Before Tax
-197
13
82
214
93
Tax
0
0
0
0
0
Net Profit
-197
13
82
214
93
EPS in ₹
-1.42
0.09
0.51
1.22
0.50

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
1,782
1,078
2,301
3,308
Fixed Assets
49
52
58
66
Current Assets
287
455
675
1,510
Capital Work in Progress
1
4
1
9
Investments
2,401
3,366
5,458
8,175
Other Assets
-669
-2,344
-3,216
-4,943
Total Liabilities
1,782
1,078
2,301
3,308
Current Liabilities
1,983
2,799
3,891
6,452
Non Current Liabilities
250
250
-682
-469
Total Equity
1,532
828
2,983
3,776
Reserve & Surplus
125
-680
1,282
1,950
Share Capital
1,409
1,511
1,700
1,827

Cash Flow

Cash Flow
2017
2021
2022
2023
2024
2025
Net Cash Flow
4
164
-12
43
41
78
Investing Activities
-32
-374
-723
-829
-1,882
-2,348
Operating Activities
8
257
338
593
813
1,654
Financing Activities
28
281
374
280
1,110
771

Share Holding

% Holding
Jun 2024
Nov 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
62.94 %
55.98 %
55.98 %
55.98 %
55.43 %
55.41 %
FIIs
0.00 %
8.63 %
8.85 %
8.90 %
10.76 %
10.72 %
DIIs
0.00 %
9.57 %
9.83 %
9.70 %
15.06 %
15.31 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
4.71 %
4.43 %
4.23 %
5.44 %
5.40 %
Others
37.06 %
21.12 %
20.92 %
21.19 %
13.30 %
13.17 %
No of Share Holders
86
1,60,440
1,46,255
1,36,017
1,54,883
1,58,550

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
31 Mar 2022 CHANGE OF NAME Change Of Name
NA
31 Mar 2022 0.00 0.00
25 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 Nov 2024 73.95 73.72
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2025 76.34 81.17
07 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 May 2025 82.33 80.85
31 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jul 2025 86.84 85.17
26 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Aug 2025 85.17 83.96
03 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
03 Nov 2025 74.63 75.41

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication1 day ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome2 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release2 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation2 days ago
Statement Of Deviation Or Variation For Quarter Ended September 20252 days ago
Board Meeting Outcome for Outcome Of The Board Meeting Held On November 03 20252 days ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot2 days ago
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer5 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation8 days ago
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 20258 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 01, 2025
Closure of Trading WindowSep 30, 2025
Disclosure Under Regulation 30 For Receipt Of Approval From IRDAI For The Appointment Of Mr. Milind Gajanan Barve As The Chairman Of The Board Of DirectorsSep 24, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 18, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 15, 2025
Announcement under Regulation 30 (LODR)-CessationAug 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 27, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 27, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 26, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2025
Grant Of Stock OptionsAug 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 31, 2025
Letter To Shareholders Regarding Notice Of The 17Th Annual General MeetingJul 31, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jul 31, 2025
Reg. 34 (1) Annual Report.Jul 31, 2025
Notice Of 17Th AGM Scheduled To Be Held On Tuesday August 26 2025 At 02:30 P.M.(IST) Through VC/OAVMJul 31, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 31, 2025
Statement Of Deviation/Variation- Quarter Ended June 30 2025Jul 31, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On July 31 2025Jul 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 24, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended June 30 2025.Jul 24, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 22, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 03, 2025
Closure of Trading WindowJun 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJun 30, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 30, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJun 27, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJun 26, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 14, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 09, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 05, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 04, 2025
Reporting Of Sale Of SharesJun 03, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
284965
0.08%
0.08%
Tata Multi Asset Allocation Fund Direct - Growth
1.38%
250000
-0.03%
0.12%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
160925
0.08%
0.08%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
108811
0.08%
0.08%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
60330
0.08%
0.08%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.25%
57769
0.08%
0.08%
Motilal Oswal Nifty 500 Index Fund Direct - Growth
0.03%
30208
0.01%
0.01%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.26%
23482
0.09%
0.09%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.26%
21208
0.09%
0.26%
Groww Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
12312
0.08%
0.08%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.06%
10936
0.02%
0.02%
SBI Nifty 500 Index Fund Direct-Growth
0.03%
9659
0.01%
0.01%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.25%
6672
0.08%
0.07%
Axis Nifty 500 Index Fund Direct-Growth
0.03%
5018
0.01%
0.01%
Kotak Nifty Smallcap 250 Index Fund Direct-Growth
0.25%
3711
0.08%
0.08%
Groww Nifty Total Market Index Fund Direct - Growth
0.03%
3639
0.01%
0.01%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.21%
-883
0.00%
-0.01%
Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth
0.06%
780
0.02%
0.02%
Angel One Nifty Total Market Index Fund Direct - Growth
0.03%
558
0.01%
0.01%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.03%
508
0.01%
0.01%
ICICI Prudential Nifty 500 Index Fund Direct-Growth
0.03%
501
0.01%
0.01%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.03%
440
0.01%
0.01%
DSP ELSS Tax Saver Fund Direct Plan-Growth
0.85%
0
-0.01%
-0.05%
Helios Balanced Advantage Fund Direct - Growth
0.74%
0
-0.01%
-0.05%
DSP Dynamic Asset Allocation Fund Direct-Growth
0.59%
0
-0.01%
-0.05%

Technical Indicators

RSI(14)
Neutral
46.48
ATR(14)
Volatile
2.05
STOCH(9,6)
Neutral
41.22
STOCH RSI(14)
Overbought
88.99
MACD(12,26)
Bullish
0.15
ADX(14)
Strong Trend
27.24
UO(9)
Bearish
51.45
ROC(12)
Downtrend And Accelerating
-2.03
WillR(14)
Neutral
-32.10